• By Brian Helfand, MD, PhD
  • Posted September 7, 2017

How Genetic Testing Can Benefit Your Urology Practice

An estimated 161,360 men will be diagnosed with prostate cancer in 2017; early detection is critical for successful treatment of this disease. We hope that Prostate Cancer Awareness Month will bring more men to their healthcare providers asking about prostate cancer screening or about their risk of developing this disease. Genetic testing for…

  • By Randall Kam
  • Posted September 1, 2017

Fit for the Fight: How I Ran 17 Marathons with Prostate Cancer

CANCER - I had a deep, visceral fear as my father, aunts, brother-in-law, mother-in-law, and father-in-law were stricken byt he disease over the years. In an effort to avoid being struck as well, I tried to stay healthy: running often, eating a low carb diet full of veggies and lean protein. In 2010, I took my first PSA (prostate specific antigen)…

  • By Jackie Connor
  • Posted November 3, 2016

Ambry Supports 'Movember' with Clinical Research, Testing Menu Updates and...Mustaches

The many male faces at Ambry are becoming a little scruffier in support of ‘Movember,’ an initiative dedicated to raising awareness about men’s health. While our guys forgo the barber and/or a daily shave, at Ambry, the meaning behind ‘Movember’ goes deeper than the mustachioed men on campus. Ambry’s constant push for more clinical…

  • By Jackie Connor
  • Posted October 12, 2016

New Study Reflects Need for Genetic Testing for Prostate Cancer Patients

The New England Journal of Medicine (NEJM) recently released a study, which concluded that 11.8% of metastatic prostate cancer cases were caused by germline gene mutations leading to hereditary prostate cancer. The study involved 692 men from the United States and United Kingdom who have documented metastatic prostate cancer. Eighty-four germline…